SNT 3.45% 3.0¢ syntara limited

re: Ann: Pharmaxis Announces Positive Combine... Once approved...

  1. 163 Posts.
    re: Ann: Pharmaxis Announces Positive Combine... Once approved Pharmaxis are aiming for sales of Bronchitol to match those of Pulmozyme which were $460 million USD in 2009.

    If they can do this we are looking at a share price many times higher than what we have today.

    I think once european approval is granted we will see further share price appreciation.


    wiljon.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.0¢
Change
0.001(3.45%)
Mkt cap ! $35.82M
Open High Low Value Volume
2.9¢ 3.0¢ 2.8¢ $49.35K 1.726M

Buyers (Bids)

No. Vol. Price($)
1 100000 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 709077 2
View Market Depth
Last trade - 16.10pm 09/07/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.